X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5470) 5470
Publication (763) 763
Book Review (53) 53
Book Chapter (29) 29
Book / eBook (25) 25
Magazine Article (11) 11
Dissertation (8) 8
Conference Proceeding (6) 6
Government Document (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4977) 4977
female (3622) 3622
papillomaviridae - immunology (2499) 2499
adult (1994) 1994
index medicus (1900) 1900
papillomaviridae - genetics (1844) 1844
human papillomavirus (1614) 1614
middle aged (1430) 1430
papillomaviridae - isolation & purification (1421) 1421
male (1366) 1366
papillomavirus infections (1327) 1327
papillomavirus infections - virology (1304) 1304
animals (1208) 1208
cancer (1178) 1178
immunology (1165) 1165
uterine cervical neoplasms - virology (1102) 1102
cervical cancer (1082) 1082
oncology (936) 936
adolescent (911) 911
virology (890) 890
papillomavirus infections - immunology (860) 860
papillomavirus infections - prevention & control (843) 843
aged (838) 838
infection (814) 814
infectious diseases (807) 807
papillomavirus infections - epidemiology (803) 803
prevalence (782) 782
women (748) 748
hpv (734) 734
risk factors (711) 711
papillomaviridae - classification (697) 697
papillomavirus infections - complications (695) 695
dna (640) 640
papillomaviridae (634) 634
dna, viral - analysis (602) 602
vaccination (585) 585
tumor virus infections - immunology (566) 566
mice (558) 558
papillomaviruses (550) 550
health aspects (549) 549
microbiology (544) 544
uterine cervical neoplasms - prevention & control (540) 540
uterine cervical neoplasms - immunology (526) 526
polymerase chain reaction (525) 525
viruses (521) 521
cervical-cancer (520) 520
oncogene proteins, viral - immunology (517) 517
young adult (511) 511
infections (509) 509
vaccines (482) 482
research article (463) 463
papillomaviridae - pathogenicity (448) 448
research (440) 440
papillomavirus infections - diagnosis (439) 439
genotype (438) 438
cervical intraepithelial neoplasia (418) 418
immunization (418) 418
virus diseases (415) 415
virus-like particles (411) 411
cervical intraepithelial neoplasia - virology (404) 404
uterine cervical neoplasms - pathology (400) 400
risk (391) 391
lesions (390) 390
dna, viral - genetics (389) 389
molecular sequence data (387) 387
oncogene proteins, viral - genetics (377) 377
antibodies, viral - blood (371) 371
papillomavirus infections - pathology (361) 361
carcinoma, squamous cell - virology (358) 358
papillomaviridae - physiology (354) 354
pathology (352) 352
intraepithelial neoplasia (350) 350
analysis (345) 345
medicine, research & experimental (341) 341
expression (340) 340
papillomavirus vaccines - immunology (328) 328
medicine (323) 323
child (314) 314
epidemiology (309) 309
uterine cervical neoplasms - epidemiology (306) 306
papillomavirus vaccines (301) 301
papillomavirus e7 proteins (300) 300
proteins (300) 300
antibodies (296) 296
young-women (291) 291
antigens, viral - analysis (288) 288
multidisciplinary sciences (285) 285
prevention (282) 282
neoplasia (274) 274
article (272) 272
aged, 80 and over (268) 268
immunohistochemistry (267) 267
squamous-cell carcinoma (264) 264
base sequence (262) 262
amino acid sequence (254) 254
tumor virus infections - complications (252) 252
cervix (251) 251
natural-history (250) 250
cervix uteri - virology (249) 249
deoxyribonucleic acid--dna (248) 248
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5246) 5246
French (72) 72
Chinese (49) 49
German (40) 40
Japanese (28) 28
Spanish (19) 19
Italian (16) 16
Russian (14) 14
Polish (10) 10
Dutch (6) 6
Czech (4) 4
Finnish (3) 3
Swedish (3) 3
Danish (2) 2
Serbian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Hebrew (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Immunology, ISSN 0022-1767, 07/2002, Volume 169, Issue 1, pp. 350 - 358
Peptide-based vaccines aimed at the induction of effective T cell responses against established cancers have so far only met with limited clinical success and... 
CANCER-PATIENTS | DENDRITIC CELLS | CTL EPITOPES | IN-VIVO | CERVICAL LESIONS | MONOPHOSPHORYL LIPID-A | GENITAL WARTS | IMMUNOLOGY | NATURAL-HISTORY | YOUNG-WOMEN | CYTOTOXIC T-LYMPHOCYTES | Oncogene Proteins, Viral - administration & dosage | Oligodeoxyribonucleotides - administration & dosage | Adjuvants, Immunologic - administration & dosage | Dendritic Cells - immunology | Humans | Molecular Sequence Data | Papillomavirus E7 Proteins | Th1 Cells - immunology | CD4-Positive T-Lymphocytes - immunology | Lymphocyte Activation - immunology | Papillomaviridae - immunology | CD40 Antigens - metabolism | CD40 Ligand - metabolism | Immunization, Secondary | Injections, Subcutaneous | Peptide Fragments - immunology | Tumor Virus Infections - immunology | Papillomavirus Infections - immunology | Epitopes, T-Lymphocyte - immunology | Tumor Cells, Cultured | Dendritic Cells - metabolism | Disease Models, Animal | Amino Acid Sequence | Oligodeoxyribonucleotides - immunology | Mice, Inbred C57BL | Peptide Fragments - administration & dosage | Cells, Cultured | Vaccines, Subunit - immunology | Oncogene Proteins, Viral - biosynthesis | Tumor Virus Infections - prevention & control | Mice, Knockout | Viral Vaccines - administration & dosage | Animals | Histocompatibility Antigens Class II - immunology | Papillomavirus Infections - prevention & control | Vaccines, Subunit - administration & dosage | Mice | Oncogene Proteins, Viral - immunology | CD8-Positive T-Lymphocytes - immunology | Viral Vaccines - immunology | Cell Line, Transformed
Journal Article
The Journal of Immunology, ISSN 0022-1767, 12/2001, Volume 167, Issue 11, pp. 6471 - 6479
Two recombinant Listeria monocytogenes (rLm) strains were produced that secrete the human papilloma virus-16 (HPV-16) E7 protein expressed in HPV-16-associated... 
IN-VITRO | EPITOPE | PROTEIN | IMMUNOTHERAPY | NEOPLASIA | IMMUNOLOGICAL SELF-TOLERANCE | CERVICAL-CANCER | TYPE-16 | MICE | IMMUNOLOGY | ANTIGEN | Spleen - immunology | Bacterial Vaccines - genetics | Humans | Papillomavirus E7 Proteins | Listeria monocytogenes - immunology | Vaccines, Synthetic - immunology | Papillomaviridae - genetics | Cancer Vaccines - genetics | Tumor Cells, Cultured - pathology | Heat-Shock Proteins - genetics | Lymphocyte Activation - genetics | Papillomaviridae - immunology | Tumor Cells, Cultured - virology | Bacterial Toxins | Listeria monocytogenes - metabolism | Oncogene Proteins, Viral - genetics | Epitopes, T-Lymphocyte - immunology | Cell Line, Transformed - immunology | Oncogene Proteins, Viral - metabolism | Papillomavirus Vaccines | Cell Line, Transformed - virology | T-Lymphocytes, Cytotoxic - immunology | Transforming Growth Factor beta - immunology | Cytotoxicity, Immunologic - genetics | Tumor Cells, Cultured - immunology | Genetic Vectors - immunology | Antineoplastic Agents - immunology | Hemolysin Proteins | Genetic Vectors - chemical synthesis | Mice, Inbred C57BL | Vaccines, Synthetic - genetics | Interferon-gamma - physiology | Spleen - cytology | Gene Expression Regulation, Viral - immunology | Oncogene Proteins, Viral - biosynthesis | Heat-Shock Proteins - immunology | Cell Line, Transformed - pathology | Cancer Vaccines - immunology | Animals | Bacterial Vaccines - immunology | CD4-Positive T-Lymphocytes - transplantation | Listeria monocytogenes - genetics | Mice | Oncogene Proteins, Viral - immunology | CD8-Positive T-Lymphocytes - immunology | Transforming Growth Factor beta - metabolism
Journal Article
Cancer Immunology, Immunotherapy: other biological response modifications, ISSN 0340-7004, 04/2016, Volume 65, Issue 4, pp. 393 - 403
Journal Article
Cancer Immunology and Immunotherapy, ISSN 0340-7004, 2012, Volume 61, Issue 9, pp. 1485 - 1492
Journal Article
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 11, pp. 2522 - 2530
Abstract Patients with human papillomavirus (HPV) positive tonsillar and base of tongue squamous cell carcinoma (TSCC and BOTSCC, respectively) have a better... 
Hematology, Oncology and Palliative Medicine | CD8+ TILs | Clinical outcome | Base of tongue cancer | CD4+ TILs | Tonsillar cancer | HPV | CD4 | CD8 | TILs | HEAD | PROGNOSIS | VACCINE | RISK | CERVICAL-CANCER | NECK-CANCER | ONCOLOGY | CD4(+) TILs | OROPHARYNGEAL CANCER | CD8(+) TILs | EPIDEMIC | EXPRESSION | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Tonsillar Neoplasms - immunology | CD4-Positive T-Lymphocytes - immunology | Papillomaviridae - immunology | Squamous Cell Carcinoma of Head and Neck | Tongue Neoplasms - virology | Aged, 80 and over | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Tonsillar Neoplasms - therapy | Tonsillar Neoplasms - pathology | Tongue Neoplasms - therapy | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Treatment Outcome | Papillomaviridae - isolation & purification | Carcinoma, Squamous Cell - immunology | Tongue Neoplasms - pathology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - immunology | Pilot Projects | Tonsillar Neoplasms - virology | Aged | Tongue Neoplasms - immunology | CD8-Positive T-Lymphocytes - immunology | Biomarkers, Tumor - immunology | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Virus Research, ISSN 0168-1702, 03/2017, Volume 231, pp. 166 - 175
Infections with sexually transmitted high-risk Human Papillomavirus (hrHPV), of which there are at least 15 genotypes, are responsible for a tremendous disease... 
HPV infection and disease | Human papillomavirus (HPV) vaccine | Squamous cell cancer (SCC) | Cutaneous and anogenital warts (condylomata) | Minor capsid protein (L2) | Cervical cancer (CxCa) | L1 PROTEIN | CROSS-NEUTRALIZATION | CELL-SURFACE | MINOR CAPSID PROTEIN | INTRAEPITHELIAL NEOPLASIA | HPV-16/18 AS04-ADJUVANTED VACCINE | IN-VITRO | VIROLOGY | VIRUS-LIKE PARTICLES | COMMON NEUTRALIZATION EPITOPE | IMMUNOGENIC DISPLAY | Immunogenicity, Vaccine | Recombinant Fusion Proteins - immunology | Head and Neck Neoplasms - virology | Oncogene Proteins, Viral - chemistry | Papillomaviridae - drug effects | Humans | Vaccination | Cross Protection | Papillomavirus Vaccines - biosynthesis | Uterine Cervical Neoplasms - pathology | Epitopes - immunology | Papillomavirus Infections - pathology | Papillomaviridae - immunology | Capsid Proteins - chemistry | Vaccines, Virus-Like Particle | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Antibodies, Viral - biosynthesis | Head and Neck Neoplasms - prevention & control | Papillomaviridae - growth & development | Cancer Vaccines - administration & dosage | Cancer Vaccines - biosynthesis | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaccines, Subunit - immunology | Recombinant Fusion Proteins - chemistry | Head and Neck Neoplasms - pathology | Papillomaviridae - pathogenicity | Cancer Vaccines - immunology | Head and Neck Neoplasms - immunology | Animals | Vaccines, Subunit - biosynthesis | Antibodies, Neutralizing - biosynthesis | Papillomavirus Infections - prevention & control | Vaccines, Subunit - administration & dosage | Immunity, Humoral - drug effects | Recombinant Fusion Proteins - genetics | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Epitopes - chemistry | Mice | Oncogene Proteins, Viral - immunology | Capsid Proteins - genetics | Prevention | Vaccines | Viral proteins | Health aspects | Papillomavirus infections | Wildlife conservation | Peptides | Development and progression | Papillomaviruses | Warts | Sexually transmitted diseases | Analysis | Skin | Cervical cancer | Antigenic determinants | Human Papillomavirus (HPV) Vaccine | Cervical Cancer (CxCa) | Minor Capsid Protein (L2) | Squamous Cell Cancer (SCC) | cutaneous and anogenital warts (condylomata)
Journal Article
Journal Article
Journal Article
Immunologic Research, ISSN 0257-277X, 04/2017, Volume 65, Issue 2, pp. 564 - 571
Etiology, pathogenesis, and immunology of systemic lupus erythematosus (SLE) form a complex, still undeciphered picture that recently has been further made... 
HERV | Crossreactivity | EBV | SLE | HPV | LOW-SIMILARITY | AUTOANTIGEN | IMMUNOLOGY | TYROSINE-PHOSPHATASE | DEFICIENCY | ENDOGENOUS RETROVIRUSES | FUNCTIONAL VARIANT | MOLECULAR MIMICRY | ASSOCIATION | EXPRESSION | EPSTEIN-BARR-VIRUS | Autoimmunity | Epitope Mapping | Humans | Antigens, CD19 - genetics | Antibodies, Viral - blood | Receptors, Natural Killer Cell - immunology | Ku Autoantigen - genetics | Papillomaviridae - immunology | Peptide Fragments - immunology | Lupus Erythematosus, Systemic - immunology | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Peptide Fragments - genetics | Antigens, CD19 - immunology | Oncogene Proteins, Viral - metabolism | Peptide Fragments - metabolism | Complement C4 - metabolism | Capsid Proteins - metabolism | Lupus Erythematosus, Systemic - virology | Receptors, Natural Killer Cell - metabolism | Ku Autoantigen - immunology | Ku Autoantigen - metabolism | Complement C4 - immunology | Complement C4 - genetics | Cross Reactions | Papillomavirus Vaccines - immunology | Antigens, CD19 - metabolism | Oncogene Proteins, Viral - immunology | Capsid Proteins - genetics | Receptors, Natural Killer Cell - genetics | Proteins | Lupus | Antigens | Killer cells | Systemic lupus erythematosus | Analysis | Transplantation of organs, tissues, etc | Development and progression | Health aspects | Papillomavirus infections | Human papillomavirus | Hypotheses | Immune response | Immunology | Peptides | Autoimmune diseases
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2013, Volume 8, Issue 9, p. e74797
Objectives: In order to assess HPV-specific IgG characteristics, we evaluated multiple aspects of the humoral antibody response that will provide insight in... 
IMMUNOGENICITY | ASSAY | EFFICACY | MARKER | SAFETY | MULTIDISCIPLINARY SCIENCES | RISK | HUMAN-PAPILLOMAVIRUS INFECTIONS | PREVALENCE | SEROPREVALENCE | VACCINES | Human papillomavirus 18 - immunology | Species Specificity | Humans | Middle Aged | Vaccination | Child, Preschool | Antibody Affinity - immunology | Infant | Human papillomavirus 16 - immunology | Antibodies, Viral - blood | Papillomavirus Infections - blood | Young Adult | Antibodies, Neutralizing - immunology | Papillomaviridae - immunology | Immunoglobulin G - immunology | Papillomavirus Infections - immunology | Adult | Female | Papillomavirus Infections - virology | Child | Infant, Newborn | Antibody Formation - immunology | Cross Reactions - immunology | Papillomavirus Infections - prevention & control | Adolescent | Antibodies, Viral - immunology | Papillomavirus Vaccines - immunology | Aged | Antigen-antibody reactions | Infection | Medical research | Immunoglobulin G | Medicine, Experimental | Health aspects | Multiplexing | Immunoassay | Laboratories | Antibodies | Homology | Infections | Vaccines | Epidemiology | Medical ethics | Antibody response | Human papillomavirus | Inhibition | Age | Public health | Immune system | Immunoglobulins | Immune response | Cross-reactivity | Immune response (humoral) | Pathology | Infectious diseases | Reactivity | Surveillance | Womens health | Neutralizing | Avidity | Cervical cancer
Journal Article